TransCode Therapeutics Announces Article Published in the Journal Cancers Detailing the Potential for Short RNA-based Drugs in Cancer and a Broad Range of Disorders
23 mars 2022 09h00 HE
|
TransCode Therapeutics, Inc.
BOSTON, March 23, 2022 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to defeating cancer using RNA therapeutics, in collaboration with teams...
TransCode Therapeutics Announces Expansion of Global RNA Oncology Patent Portfolio
14 févr. 2022 09h00 HE
|
TransCode Therapeutics, Inc.
BOSTON, Feb. 14, 2022 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to defeating cancer using RNA therapeutics, today announced that it has...
CORRECTION --TransCode Therapeutics
10 févr. 2022 09h46 HE
|
TransCode Therapeutics, Inc.
BOSTON, Feb. 10, 2022 (GLOBE NEWSWIRE) -- In a release issued under the headline "TransCode Therapeutics to Present at 2020 BIO CEO & INVESTOR CONFERENCE" earlier today by TransCode...
TransCode Therapeutics to Present at 2020 BIO CEO & INVESTOR CONFERENCE
10 févr. 2022 08h30 HE
|
TransCode Therapeutics, Inc.
BOSTON, Feb. 10, 2022 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) today announced that it will be presenting at the 2022 BIO CEO & Investor Conference. TransCode’s Chief...
TransCode Therapeutics To Participate at H.C. Wainwright BioConnect Conference
06 janv. 2022 15h17 HE
|
TransCode Therapeutics, Inc.
BOSTON, Jan. 06, 2022 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) today announced that it will be attending and presenting at the H.C. Wainwright BioConnect Conference....
TransCode Therapeutics To Participate at MedInvest Oncology Investor Conference
06 déc. 2021 19h10 HE
|
TransCode Therapeutics, Inc.
BOSTON, Dec. 06, 2021 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) today announced that it will be attending and presenting at the MedInvest Oncology Investor Conference....